Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised

Report - Highlights of the 15th Industry Standing Group (ISG) meeting

One substance - one assessment (OSOA): EU collaboration on chemicals-related data

Questions and answers regarding co-processed excipients used in solid oral dosage forms

Human medicines European public assessment report (EPAR): Dexdor, dexmedetomidine, Date of authorisation: 15/09/2011, Revision: 18, Status: Authorised

Quality of medicines questions and answers: Part 1

Human medicines European public assessment report (EPAR): Tadalafil Lilly, tadalafil, Date of authorisation: 22/03/2017, Revision: 8, Status: Authorised

List of medicinal products under additional monitoring

List of medicinal products under additional monitoring